A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients: A comparison with angiotensin-converting enzyme inhibitors

International Heart Journal

Volumn 49, Issue 1, 2008, Pages 95-103

  Sonoda, Makoto ^a   Aoyagi, Teruhiko ^b   Takenaka, Katsu ^b   Uno, Kansei ^b   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

ACE inhibitors; Atherosclerosis; B mode ultrasound; Intima media thickness

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; ENALAPRIL; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIDAPRIL; LOSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAZOLIDINE DERIVATIVE;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; COUGHING; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; COMPARATIVE STUDY; DRUG EFFECT; ECHOGRAPHY; INTIMA; MIDDLE AGED; TUNICA MEDIA;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; CAROTID ARTERY, COMMON; ENALAPRIL; HUMANS; HYPERTENSION; IMIDAZOLIDINES; LOSARTAN; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 43249111032     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.95     Document Type: Article

References (21)

1. Bonithon-Kopp C, Ducimetière P, Touboul PJ, et al. Plama angiotensin-converting enzyme activity and carotid wall thickening. Circulation 1994; 89: 952-4.
2. Migdalis IN, Gerolimou B, Kozanidou G, Hatzigakis SM, Karmaniolas KD. Effect of fosinopril sodium on early carotid atherosclerosis in diabetic patients with hypertension. J Med 1997; 28: 371-80.
3. Boutouyrie P, Bussy C, Hayoz D, et al. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation 2000; 101: 2601-6.
4. Miyazaki M, Takai S, Involvement of angiotensin II in development of atherosclerosis. Nippon Rinsho 2002; 60: 1904-10.
5. Ferrario CM. Use of angiotensin II receptor blockers in animal models of atherosclerosis. Am J Hypertens 2002; 15:9S-13.
6. Ludwig M, Stapff M, Ribeiro A, et al. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin Ther 2002; 24: 1175-93.
7. Urata H, Garten D. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase. Eur Heart J 1993; 14: 177-82.
8. Okunishi H, Oka Y, Shiota N, Kawamoto T, Song K, Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 1993; 62:207-10.
9. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study Circulation 1997; 96: 1432-7.
10. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 15: 128: 262-9.
11. O'Leary DH, Polak JF, Kronm RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
12. Simons PC, Algra A, Bots ML, Grobbee DE, Van der Graaf Y. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients: The SMART Study (Second Manifestations of ARTerial disease). Circulation 1999; 100: 951-7.
13. Poli A, Tremoli E, Colombo A, Sintori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: A new model for the quantitation and follow-up of preclinical atherosclerosis. Atherosclerosis 1988; 70:253-61.
14. Reis KA, Guz G, Ozdemir H, et al Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease. Int Heart J 2005; 46: 255-64.
15. Davis PH, Dowson JD, Mahoney LT, Lauer RM. Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study Circulation 1999; 100: 838-42.
16. Course JR 3rd, Thompson CJ. An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. Circulation 1993; 87:II17-33.
17. Furberg CD, Adams HP Jr, Applegate WB, et al. Effects of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research group. Circulation 1994; 90:1679-87.
18. Mercuri M, Bond MG, Sirtori CR, et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med 1996; 101: 627-34.
19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
20. Tedeschi C, Guarini P, Giordano G, et al. Effects of nicardipine on intimal-medial thickness and arterial distensibility in hypertensive patients. Preliminary results after 6 months. Int Angiol 1993; 12: 344-7.
21. Schmidt-Ott KM, Kagiyama S, Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regul Pept 2000; 93: 65-77.